Patent · US Expired

Glutaminyl based DPIV inhibitors

US7060719B2 · kind B2 · utility

1Cited by

2References

18Claims

0Family size

Assignee

Prosidion Limited · GB

Inventors

Hans-Ulrich Demuth · Halle (Saale), DE
Torsten Hoffmann · Weil am Rhein, DE
Ulrich Heiser · Halle (Saale), DE

Key dates

Filing date	Feb 13, 2004
Grant date	Jun 13, 2006
Priority date	—
Expiry date	Feb 13, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of the formula:wherein X=CH2 or S or pharmaceutical acceptable salts thereof useful for treating conditions mediated by DPIV or DPIV-like enzymes, such as arthritis, obesity, immune and autoimmune disorders, allograft transplantation, cancer, neuronal disorders and dermal diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.